cbdMD Announces Inferno Freeze: Our Most Powerful Topical
cbdMD (NYSE American: YCBD) has launched Inferno Freeze, its most powerful topical product designed for athletes and fitness enthusiasts. The new product features an advanced full-spectrum formula containing 3000mg CBD, 500mg CBDa, and 50mg THC combined with cooling agents including 4% Menthol, 3% Camphor, and 0.04% Capsaicin.
The product utilizes nano-technology for enhanced absorption and effectiveness, incorporating USA-grown hemp and non-GMO ingredients. This launch expands cbdMD's topicals line and complements their existing portfolio of ingestibles, pet products, functional mushrooms, and hemp-derived beverages.
cbdMD (NYSE American: YCBD) ha lanciato Inferno Freeze, il suo prodotto topico più potente pensato per atleti e appassionati di fitness. Il nuovo prodotto presenta una formula avanzata a spettro completo contenente 3000 mg di CBD, 500 mg di CBDa e 50 mg di THC, combinata con agenti rinfrescanti tra cui 4% mentolo, 3% camforo e 0,04% capsicina.
Il prodotto utilizza nanotecnologia per un'assorbimento e un'efficacia migliorati, impiegando canapa coltivata negli USA e ingredienti non-GMO. Questa novità amplia la linea di topici di cbdMD e si integra con il loro portafoglio esistente di integratori alimentari, prodotti per animali, funghi funzionali e bevande a base di canapa.
cbdMD (NYSE American: YCBD) ha lanzado Inferno Freeze, su producto tópico más potente diseñado para atletas y entusiastas del fitness. El nuevo producto presenta una fórmula avanzada de espectro completo que contiene 3000 mg de CBD, 500 mg de CBDa y 50 mg de THC, combinada con agentes refrescantes que incluyen 4% de mentol, 3% de alcanfor y 0,04% de capsaicina.
El producto utiliza nanotecnología para una mayor absorción y eficacia, incorporando cáñamo cultivado en Estados Unidos e ingredientes no-GMO. Este lanzamiento amplía la línea de tópicos de cbdMD y complementa su portafolio existente de ingestibles, productos para mascotas, hongos funcionales y bebidas derivadas del cáñamo.
cbdMD (NYSE American: YCBD)가 운동선수와 피트니스 애호가를 위해 설계된 가장 강력한 외용제 Inferno Freeze를 출시했습니다. 새로운 제품은 3000mg CBD, 500mg CBDa, 50mg THC를 포함한 고급 풀스펙트럼 포뮬러에 4% 멘톨, 3% 캠포, 0.04% 캡사이신 등의 냉각 성분을 결합했습니다.
이 제품은 흡수력과 효과를 높이기 위해 나노기술을 활용하며 미국산 대마와 비-GMO 성분을 포함합니다. 이번 출시로 cbdMD의 탑컬 라인이 확장되고 기존의 경구용 제품, 반려동물용 products, 기능성 버섯, 대마유래 음료 포트폴리오를 보완합니다.
cbdMD (NYSE American: YCBD) a lancé Inferno Freeze, son produit topique le plus puissant conçu pour les athlètes et les passionnés de fitness. Le nouveau produit présente une formule avancée à spectre complet contenant 3000 mg de CBD, 500 mg de CBDa et 50 mg de THC, associée à des agents rafraîchissants comprenant 4% de menthol, 3% de camphre et 0,04% de capsaïcine.
Le produit utilise une nanotechnologie pour une meilleure absorption et efficacité, en incorporant du chanvre cultivé aux États-Unis et des ingrédients non-OGM. Ce lancement élargit la gamme de topiques de cbdMD et complète leur portefeuille existant d’ingestibles, de produits pour animaux, de champignons fonctionnels et de boissons à base de chanvre.
cbdMD (NYSE American: YCBD) hat Inferno Freeze eingeführt, sein leistungsstärkstes Topikalprodukt, das für Athleten und Fitnessbegeisterte entwickelt wurde. Das neue Produkt verfügt über eine fortschrittliche Vollspektrum-Formel mit 3000 mg CBD, 500 mg CBDa und 50 mg THC, kombiniert mit kühlenden Wirkstoffen wie 4% Menthol, 3% Kampfer und 0,04% Capsaicin.
Das Produkt nutzt Nanotechnologie für eine verbesserte Aufnahme und Wirksamkeit und enthält in den USA angebauten Hanf sowie gentechnikfreie Inhaltsstoffe. Dieser Launch erweitert das Topicals-Portfolio von cbdMD und ergänzt ihr bestehendes Angebot an Ingestibles, Haustierprodukten, funktionellen Pilzen und hanf-basierten Getränken.
cbdMD (بورصة NYSE American: YCBD) أطلقت Inferno Freeze، أقوى منتج موضعي لديها مصمم للرياضيين وهواة اللياقة البدنية. يتميز المنتج الجديد بنظام تركيبة كاملة النطاق متقدمة تحتوي على 3000mg من CBD، و500mg من CBDa، و50mg من THC مع عوامل تبريد تشمل 4% م Menthol، 3% كامفور، و0.04% كابسيسين.
يستخدم المنتج تقنية النانو لزيادة الامتصاص والفعالية، مع الاعتماد على القنب المزروع في الولايات المتحدة ومكونات غير معدلة وراثياً. هذا الإطلاق يوسع خط المنتجات الموضعية لـ cbdMD ويكمل محفظتهم الحالية من المنتجات القابلة للبلع، منتجات الحيوانات الأليفة، الفطر الوظيفي، ومشروبات القنب المستخلصة.
cbdMD (NYSE American: YCBD) 已推出 Inferno Freeze，这是面向运动员和健身爱好者的最强力外用产品。新产品采用先进的
该产品采用纳米技术以提升吸收与效力，使用美国产大麻及非转基因成分。这一推出扩充 cbdMD 的外用产品线，并与现有的口服制品、宠物产品、功能性蘑菇以及大麻衍生饮料的组合相得益彰。
- Launch of most powerful topical product with high-strength formula (3000mg CBD + 500mg CBDa + 50mg THC)
- Advanced nano-technology implementation for improved product absorption
- Expansion of product portfolio strengthening market presence
- None.
Insights
cbdMD launches premium 'Inferno Freeze' topical with high-potency cannabinoid blend, expanding product portfolio in competitive wellness market.
cbdMD's new Inferno Freeze represents a strategic product extension in the high-performance topical segment. The formulation contains
The multi-ingredient approach combining cannabinoids with
This launch aligns with cbdMD's broader portfolio strategy spanning multiple categories (ingestibles, pet products, mushrooms, beverages), indicating the company's commitment to product diversification rather than mere line extensions. By targeting the athletic recovery segment with a premium offering, cbdMD is pursuing higher-margin opportunities while reinforcing its position across the wellness spectrum.
The high THC content (
Charlotte, North Carolina--(Newsfile Corp. - September 25, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted CBD companies, and operator of the leading CBD and wellness brands cbdMD, Paw CBD, ATRx, and Herbal Oasis, today announced the launch of its newest topical innovation. Inferno Freeze is its most powerful innovation yet for athletes, fitness enthusiasts, and anyone seeking advanced recovery. Designed for high-performance relief, Inferno Freeze combines breakthrough wellness science with professional-grade strength to help bodies perform, recover, and repeat.
"Inferno Freeze embodies our mission to merge innovation with performance," said Ronan Kennedy, CEO of cbdMD. "This product was designed with athletes and other high performing individuals in mind, those who need fast, effective recovery to stay at the top of their game. With cutting-edge nano-technology and our most advanced full-spectrum formula to date, Inferno Freeze redefines what peak relief looks like."
Product Highlights: Inferno Freeze
A high-strength, full-spectrum topical packed with cannabinoids and both cooling and heating botanicals for the ultimate rapid relief and recovery.
- Intense Strength: 3000mg CBD + 500mg CBDa + 50mg THC for enhanced relief.
- Rapid Cooling:
4% Menthol,3% Camphor, and0.04% Capsaicin for soothing power. - Nano-Enhanced: Advanced nano-technology for quicker absorption and effectiveness.
- Full-Spectrum Blend: CBD, CBDa, and THC work together for amplified benefits.
- Wellness-Driven: USA-grown hemp, non-GMO, third-party tested for purity and potency.
Inferno Freeze expands cbdMD's topicals line and delivers the relief that high-level performance demands. This launch also complements cbdMD's broader portfolio, which spans ingestibles, pet products, functional mushrooms, and hemp-derived beverages.
For more product details, please visit: https://www.cbdmd.com/products/inferno-freeze.
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified using words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, including but not limited to expectations on our ability to continue as a going concern, increasing our revenues, the development or future sales of Oasis products, regaining compliance with NYSE American continued listing requirements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2024 as filed with the Securities and Exchange Commission (the "SEC") on December 17, 2024, and our other filings with the SEC. All forward-looking statements, including Euromonitor international projections, involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267954
FAQ
What is the CBD content in cbdMD's new Inferno Freeze product?
What cooling ingredients are included in YCBD's Inferno Freeze?
What technology does cbdMD use in their new Inferno Freeze product?
Is cbdMD's Inferno Freeze third-party tested?
